Compare HRTG & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HRTG | MDXG |
|---|---|---|
| Founded | 2012 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 670.9M | 607.7M |
| IPO Year | 2014 | 2007 |
| Metric | HRTG | MDXG |
|---|---|---|
| Price | $26.50 | $4.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $33.50 | $9.00 |
| AVG Volume (30 Days) | 355.6K | ★ 1.2M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 214.43 | 14.29 |
| EPS | ★ 1.19 | N/A |
| Revenue | ★ $847,330,000.00 | $418,630,000.00 |
| Revenue This Year | $7.50 | N/A |
| Revenue Next Year | $6.74 | $13.02 |
| P/E Ratio | $23.34 | ★ N/A |
| Revenue Growth | 3.71 | ★ 19.99 |
| 52 Week Low | $16.83 | $3.03 |
| 52 Week High | $31.98 | $7.99 |
| Indicator | HRTG | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 55.41 | 71.21 |
| Support Level | $25.28 | $3.50 |
| Resistance Level | $27.73 | $5.38 |
| Average True Range (ATR) | 1.04 | 0.16 |
| MACD | 0.07 | 0.03 |
| Stochastic Oscillator | 56.37 | 94.96 |
Heritage Insurance Holdings Inc is a regional property and casualty insurance company that offers a variety of personal and commercial insurance products. Through its subsidiaries, Heritage Property & Casualty Insurance, Narragansett Bay Insurance, and Zephyr Insurance, the company issues personal residential property insurance across various states in the U.S. It also offers commercial residential insurance predominantly for its Florida properties. Heritage Insurance manages insurance underwriting, customer services, actuarial analysis, distribution, and claims processing internally. The company operates in Alabama, California, Connecticut, Delaware, Florida, Georgia, Hawaii, Maryland, Massachusetts, Mississippi, New Jersey, New York, North Carolina, Rhode Island, and South Carolina.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.